Dorie Apollonio, PhD, MPP

Professor
Department of Clinical Pharmacy
Apollonio
[email protected]
Phone: +1 415 502-1942
530 Parnassus Avenue, Rm 365
UCSF Box 1390
San Francisco, CA 94143
United States

Links

UCSF Profiles

Affiliations

Education programs

PharmD Degree Program

UCSF centers, institutes, and research programs

UCSF Helen Diller Family Comprehensive Cancer Center
Center for Tobacco Control Research and Education

School committees and service

Diversity, Equity and Inclusion Committee, Center for Tobacco Control Research and Education, 2022, University of California San Francisco

What I do

My work considers the activities of industries implicated in the spread of non-communicable diseases, including tobacco, pharmaceuticals, cannabis, alcohol, and food. Some recent work has identified tobacco cessation strategies for vulnerable populations, sought to understand the scope of tobacco and cannabis co-use, assessed the spread of laws addressing new tobacco and cannabis delivery systems, and identified the extent of pharmacist prescribing. My work has been published in journals in multiple disciplines, including law, medicine, pharmacy, political science, public health, and public policy. I’ve been an instructor and research mentor in the UCSF School of Pharmacy since 2004.

Departmental research area

health services and policy research

My research expertise

health policy, substance use, tobacco control, cannabis, opioids, vulnerable populations, homelessness, mental health disorders, cancer, pharmacist furnishing

Professional background

Degrees

PhD, Political Science, University of California, Berkeley, 2003
MPP, Health Policy, Harvard University, 1994
BA, Political Science and History, Macalester College, 1992

Biography

Dr. Apollonio is Professor in the Department of Clinical Pharmacy at the University of California, San Francisco. Her research considers considers the activities of industries implicated in the spread of non-communicable diseases, including opioids, tobacco, and cannabis. Her current work includes efforts to:
-- Understand and address the role of pharmaceutical companies in the opioid crisis
-- Improve the regulation of novel cannabis products, with a focus on reducing poisonings among children
-- Increase access to medications in primary care deserts in California
-- Expand access to tobacco cessation services for people experiencing homelessness in San Francisco
-- Expand access to tobacco cessation services for residents of the San Joaquin Valley and Sierra Foothills (in partnership with the UC Merced Nicotine and Cannabis Policy Center)

Her funding record includes past and current awards at the national level from the National Institute on Drug Abuse, National Cancer Institute, and US Food & Drug Administration Tobacco Center of Regulatory Science; at the state level from the California Breast Cancer Research Program, California Department of Cannabis Control, California Tobacco-Related Disease Research Program, and University of California Cancer Research Coordinating Committee; and the institutional level from the Helen Diller Family Comprehensive Cancer Center.

Her work has been published in journals across multiple disciplines, including law, medicine, pharmacy, political science, public health, and public policy. She has served as an instructor in the UCSF School of Pharmacy since 2004, and has earned multiple teaching awards. Between 2020 and 2025, she mentored 97 PharmD students whose work in small groups resulted in 23 peer-reviewed publications.

Research keywords

  • opiates
  • cannabis
  • vulnerable populations
  • homelessness
  • mental health disorders
  • heart disease
  • sugar
  • health policy
  • cancer
  • tobacco control
  • substance use
  • Drug Overdose
  • Tobacco Use
  • smoking cessation
  • Tobacco Products
  • tobacco industry
  • cannabis
  • Commerce
  • Marketing
  • Smoking
  • pharmacists
  • Taxes
  • Community Pharmacy Services
  • pharmacies
  • Poison Control Centers
  • Public Policy

Publications

Wakefield T, Bialous S, Ling P, Apollonio DE. Efforts to secure nicotine and cannabis product placements in popular media by Ploom, Pax, and Juul: an analysis of tobacco industry documents. Nicotine Tob Res. 2025 Sep 03.
Mohammadi SM, Ling P, Apollonio DE, Bialous S. A framework for researching the waterpipe tobacco business sector in the United States. Tob Induc Dis. 2025; 23.
Wakefield TD, Iniguez R, Bialous S, Ling P, Apollonio DE. Tobacco industry efforts to harness the voice and influence of community organisations. Tob Control. 2025 Jul 18.
Schmidt LA, Jacobs LM, Matthay EC, Roake J, Lewis J, Ho R, Apollonio DE. Characteristics and Trends in Child Cannabis Exposures During Legalization in California. Am J Prev Med. 2025 Oct; 69(4):107963.
Mohammadi SM, Ling PM, Apollonio DE, Bialous S. Utilisation of waterpipe tobacco imagery in cigarette advertising: a case study of American tobacco company and RJ Reynolds tobacco company. Tob Control. 2025 Jun 24.
Schneider S, Durazo A, Rodriguez S, Chan-Golston AM, Wakefield T, Halliday DM, Tracy D, Song AV, Apollonio DE. Perceptions of pharmacist-furnished nicotine replacement therapy among participants who smoke in California. J Am Pharm Assoc (2003). 2025 Jun 12; 102450.
Ho RY, Regelman H, Ma A, Lee SY, Sandhu S, Shapiro S, Lewis J, Tsutaoka B, Apollonio DE. Changes in Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Exposures Following Recent Demand for Weight Management: A Retrospective Review of California Poison Control System Data. J Pharm Technol. 2025 May 12; 87551225251332212.
Kabella D, Apollonio D, Young H, Knight KR. The Rise of Clinical Decision Support Algorithms in Pain Management 2009-2024. J Gen Intern Med. 2025 May 12.
White JS, Atherwood S, Apollonio DE. Effect of a minimum floor price law for tobacco products on tobacco sales in Oakland, California, USA: a synthetic difference-in-differences analysis. Tob Control. 2025 Jan 19.
Kui K, Hailozian C, Thai M, Chakravarty D, Apollonio DE, Kroon L, Vijayaraghavan M. Tobacco cessation, mental health, and substance use in a community pharmacist-linked cessation program for people experiencing homelessness. Drug Alcohol Depend. 2025 Feb 01; 267:112527.
Charris R, Ahern J, Apollonio DE, Jent V, Jacobs LM, Jung S, Schmidt LA, Gruenewald P, Matthay EC. Examining the Interactive Associations of Cannabis and Alcohol Outlets With Self-harm Injuries in California: A Spatiotemporal Analysis. Epidemiology. 2025 Mar 01; 36(2):196-206.
Gac B, Tavares K, Yakubi H, Khan H, Apollonio DE, Crosbie E. Pharmaceutical industry use of key opinion leaders to market prescription opioids: A review of internal industry documents. Explor Res Clin Soc Pharm. 2024 Dec; 16:100543.
Apollonio DE, Dennehy CE, Tsourounis C, Wakefield T. An Observational Study of Regulatory Violations Related to Online Tobacco Product Marketing and Retailer Responses to US FDA Warning Letters. Tob Use Insights. 2024; 17:1179173X241300825.
Matthay EC, Charris R, Ahern J, Apollonio DE, Jent V, Jacobs LM, Jung S, Schmidt LA, Gruenewald P. Interactive associations of cannabis and alcohol outlet densities with assault injuries in California: A spatiotemporal analysis. Am J Epidemiol. 2024 Oct 02.
Lee C, Tsui A, Xu S, Apollonio DE. Evaluation of the strategies opioid manufacturers used to recruit health professionals and encourage overprescribing: an analysis of industry documents. BMC Public Health. 2024 08 08; 24(1):2153.
Herron G, Leong A, Patel K, Rasekhi K, Apollonio DE. Assessment of PrEP and PEP furnishing in San Francisco Bay Area pharmacies: An observational cross-sectional study. J Am Pharm Assoc (2003). 2024 Nov-Dec; 64(6):102201.
Matthay EC, Mousli LM, Sun C, Lewis J, Jacobs LM, Heard S, Ho R, Schmidt LA, Apollonio DE. Associations of Local Cannabis Control Policies With Harmful Cannabis Exposures Reported to the California Poison Control System. Epidemiology. 2024 Jul 01; 35(4):447-457.
Madan K, Schmidt S, Chami RF, Ho R, Lewis JC, Apollonio DE. Reported exposures to derived cannabis products in California before and after the 2018 federal reclassification of hemp. Int J Drug Policy. 2024 Feb; 124:104313.
Wakefield TD, Guillory J, Ling P, Apollonio DE. Descriptive cross-sectional survey of tobacco and cannabis restrictions on state and local film incentives in the USA. Tob Control. 2023 Nov 21.
Ghai A, Sabour E, Salonga R, Ho R, Apollonio DE. Exposures to Bleach, Peroxide, Disinfectants, Antimalarials, and Ivermectin Reported to the California Poison Control System Before and During the COVID-19 Pandemic, 2015-2021. Public Health Rep. 2024 Jan-Feb; 139(1):112-119.
Chiu C, Wong A, Chhen J, Roderos AAJ, Apollonio DE. Retail chain pharmacy opioid dispensing practices from 1997 to 2020: A content analysis of internal industry documents. Drug Alcohol Depend Rep. 2023 Dec; 9:100199.
Azad A, Su J, Nguyen M, Ly M, Wu I, Tracy D, Song A, Apollonio DE. Pharmacist furnishing of hormonal contraception in California's Central Valley. J Am Pharm Assoc (2003). 2024 Jan-Feb; 64(1):226-234.e2.
Rotering T, Bialous S, Apollonio D. Cannabis industry campaign expenditures in Colorado, 2005-2021. Int J Drug Policy. 2023 09; 119:104156.
Matthay EC, Mousli L, Apollonio DE, Schmidt LA. Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties. Int J Drug Policy. 2023 09; 119:104114.
De Los Reyes G, Ng A, Valencia Chavez J, Apollonio DE, Kroon L, Lee P, Vijayaraghavan M. Evaluation of a Pharmacist-Linked Smoking Cessation Intervention for Adults Experiencing Homelessness. Subst Use Misuse. 2023; 58(12):1519-1527.
Gac B, Yakubi H, Apollonio DE. Issues arising from the study design, conduct, and promotion of clinical trials funded by opioid manufacturers: a review of internal pharmaceutical industry documents. Evidence & Policy. 2023; 4(19):536-553.
Chu E, Cocos G, Lee HJ, Go J, Lewis J, Apollonio DE. Trends in concomitant and single opioid and benzodiazepine exposures reported to the California Poison Control System following the Centers for Disease Control and Prevention release of opioid guidelines in 2016. Clin Toxicol (Phila). 2023 04; 61(4):305-311.
Wakefield T, Bialous S, Apollonio DE. Clearing cannabis criminal records: A survey of criminal record expungement availability and accessibility among US States and Washington DC that decriminalized or legalized cannabis. Int J Drug Policy. 2023 04; 114:103983.
Orta J, Barton C, Ilao P, Apollonio DE. A review of policies on the involuntary use of psychotropic medications among persons experiencing incarceration in the United States. Health Justice. 2023 Feb 18; 11(1):9.
Banawis M, Mah G, Mohsin R, Pobre J, Tracy D, Song AV, Apollonio DE. An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):566-573.
Yakubi H, Gac B, Apollonio DE. Industry strategies to market opioids to children and women in the USA: a content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P. et al. BMJ Open. 2022 11 02; 12(11):e052636.
Apollonio DE. Marketing Antipsychotics to Correctional Facilities: A Review of Pharmaceutical Industry Documents. J Correct Health Care. 2022 10; 28(5):325-328.
Matthay EC, Mousli LM, Fu C, Zhang S, Ponicki WR, Gruenewald P, Apollonio DE, Schmidt LA. Equity in Coverage of Local Cannabis Control Policies in California, 2020‒2021. Am J Public Health. 2022 11; 112(11):1640-1650.
Wakefield T, Glantz SA, Apollonio DE. Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US. JAMA Netw Open. 2022 08 01; 5(8):e2228088.
Yakubi H, Gac B, Apollonio DE. Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al. J Health Polit Policy Law. 2022 08 01; 47(4):453-472.
Caleb Alexander G, Mix LA, Choudhury S, Taketa R, Tomori C, Mooghali M, Fan A, Mars S, Ciccarone D, Patton M, Apollonio DE, Schmidt L, Steinman MA, Greene J, Ling PM, Seymour AK, Glantz S, Tasker K. The Opioid Industry Documents Archive: A Living Digital Repository. Am J Public Health. 2022 08; 112(8):1126-1129.
Matthay EC, Mousli L, Ponicki WR, Glymour MM, Apollonio DE, Schmidt LA, Gruenewald P. A Spatiotemporal Analysis of the Association of California City and County Cannabis Policies with Cannabis Outlet Densities. Epidemiology. 2022 09 01; 33(5):715-725.
Choi AJ, Hean AC, Lee JK, Tran ND, Lin TK, Apollonio DE. A Retrospective Global Assessment of Factors Associated With COVID-19 Policies and Health Outcomes. Front Public Health. 2022; 10:843445.
Carlson Z, Pham S, El-Sokkary J, Apollonio DE. Cannabis use prevalence among Baby Boomers before and after implementation of recreational retail sales in California. Subst Abuse Treat Prev Policy. 2022 03 05; 17(1):17.
Hartman-Filson M, Chen J, Lee P, Phan M, Apollonio DE, Kroon L, Donald F, Vijayaraghavan M. A community-based tobacco cessation program for individuals experiencing homelessness. Addict Behav. 2022 06; 129:107282.
Rotering T, Apollonio DE. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021. Int J Drug Policy. 2022 04; 102:103585.
Roth W, Tam M, Bi C, Kim J, Lewis J, Ho R, Apollonio DE. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic. Clin Toxicol (Phila). 2022 May; 60(5):632-638.
Bellman R, Mohebbi S, Nobahar N, Parizher J, Apollonio DE. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies. J Am Pharm Assoc (2003). 2022 Jan-Feb; 62(1):370-377.e3.
Driller G, Plasencia E, Apollonio DE. Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations. BMJ Open. 2021 03 02; 11(3):e043133.
Apollonio DE, Dutra LM, Glantz SA. Associations between smoking trajectories, smoke-free laws and cigarette taxes in a longitudinal sample of youth and young adults. PLoS One. 2021; 16(2):e0246321.
Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev. 2020 12 03; 12:CD013413.
Chen L, Lim J, Jeong A, Apollonio DE. Implementing law into practice: hormonal contraceptive furnishing in San Francisco community pharmacies. Birth Control Pharmacist. 2020.
Nguyen AM, Kearney TE, Apollonio DE. Evaluation of naloxone furnishing community pharmacies in San Francisco. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):1050-1057.e1.
Wu A, Phan C, Nguyen KC, Quindoy M, Lewis J, Apollonio DE. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling. Clin Toxicol (Phila). 2021 Apr; 59(4):313-319.
Chen L, Lim J, Jeong A, Apollonio DE. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):963-968.e2.
Pasetes SV, Ling PM, Apollonio DE. Cognitive performance effects of nicotine and industry affiliation: a systematic review. Subst Abuse. 2020; 14:1178221820926545.
Apollonio DE, Glantz SA. Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents. Nicotine Tob Res. 2020 05 26; 22(6):967-974.
Apollonio DE, Glantz S. Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents. Tob Control. 2020 12; 29(e1):e10-e17.
Wiltse DL, La Raja RJ, Apollonio DE. Typologies of Party Finance Systems: A Comparative Study of How Countries Regulate Party Finance and Their Institutional Foundations. Elect Law J. 2019 Sep; 18(3):243-261.
Maya Vijayaraghavan, Holly Elser, Dorie Apollonio. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database of Systematic Reviews. 2019 Sep 2; (9).
Kearns CE, Glantz SA, Apollonio DE. In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign. BMC Public Health. 2019 Aug 22; 19(1):1150.
Pimentel L, Apollonio DE. Placement and sales of tobacco products and nicotine replacement therapy in tobacco-free and tobacco-selling pharmacies in Northern California: an observational study. BMJ Open. 2019 06 14; 9(6):e025603.
Huey J, Apollonio DE. A Review of Tobacco Policies on University of California Campuses. Calif J Health Promot. 2019 Jun; 17(1):24-30.
David L. Wiltse, Raymond J. La Raja, Dorie E. Apollonio. Typologies of Party Finance Systems: A Comparative Study of How Countries Regulate Party Finance and Their Institutional Foundations. Election Law Journal Rules Politics and Policy. 2019 Apr 30; 18(3):243-261.
Apollonio DE, Spetz J, Schmidt L, Jacobs L, Kaur M, Ramo D. Prevalence and Correlates of Simultaneous and Separate 30-Day Use of Tobacco and Cannabis: Results from the California Adult Tobacco Survey. Subst Use Misuse. 2019; 54(10):1627-1632.
Vijayaraghavan M, Apollonio DE. Engaging Adults Experiencing Homelessness in Smoking Cessation Through Large-Scale Community Service Events. Health Promot Pract. 2019 05; 20(3):325-327.
Apollonio DE, Broyde K, Azzam A, De Guia M, Heilman J, Brock T. Pharmacy students can improve access to quality medicines information by editing Wikipedia articles. BMC Med Educ. 2018 Nov 20; 18(1):265.
Brock T, Apollonio DE. Paving the desire paths of health information needs: Teaching students to edit Wikipedia. BMC Series blog . 2018.
Huey J, Apollonio DE. A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC Public Health. 2018 Sep 17; 18(1):1129.
Apollonio DE, Glantz SA. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2019 05; 28(3):274-281.
Kearns C, Schmidt L, Apollonio D, Glantz S. The sugar industry's influence on policy. Science. 2018 05 04; 360(6388):501.
Kearns CE, Apollonio D, Glantz SA. Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol. 2017 Nov; 15(11):e2003460.
Gruenberg K, Apollonio D, MacDougall C, Brock T. Sustainable Pharmacy: Piloting a Session on Pharmaceuticals, Climate Change, and Sustainability within a U.S. Pharmacy Curriculum. Innov Pharm. 2017; 8(4).
Katherine Gruenberg, Dorie Apollonio, Conan MacDougall, Tina Brock. Sustainable Pharmacy: Piloting a Session on Pharmaceuticals, Climate Change, and Sustainability within a U.S. Pharmacy Curriculum. INNOVATIONS in pharmacy. 2017 Oct 12; 8(4):3.
Apollonio D, Glantz SA. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health. 2017 10; 107(10):1636-1642.
Sung H, Apollonio DE. Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs. Health Promot Pract. 2017 07; 18(4):571-580.
Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738.
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274.
Apollonio DE, Wolfe N, Bero LA. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822.
Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141.
Apollonio DE, Glantz SA. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 07; 106(7):1200-7.
Dorie Apollonio. Organized Labor : Adaptive Strategies in Challenging Times. . 2016 Jan 1; 207-223.
Krauth D, Apollonio DE. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis. 2015; 13:33.
Krauth D, Apollonio D. Accuracy of popular media reporting on tobacco cessation therapy in substance abuse and mental health populations. BMJ Open. 2015 Mar 26; 5(3):e007169.
Lochner T, Apollonio DE. Karma police: Prosecutorial strategies in obscenity cases and the broader cultural war. Syracuse Law and Civic Engagement Forum. 2015; (2):1-24.
Apollonio DE. Tobacco industry efforts to influence policy: when interest groups face opposition. Interest Group Politics. 2015.
Lochner T, Apollonio D. Karma Police: Prosecutorial Strategies in Obscenity Cases and the Broader Culture War. Syracuse Law Civ Engagem. 2014; 2.
Apollonio DE. Political advocacy in pharmacy: challenges and opportunities. Integr Pharm Res Pract. 2014; 3:89-95.
Apollonio DE, Glantz SA, Bero LA. Term limits and the tobacco industry. Soc Sci Med. 2014 Mar; 104:1-5.
Apollonio D, Lochner T, Heddens M. Immigration and Prosecutorial Discretion. Calif J Politics Policy. 2013; 5(2):232-251.
Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Database Syst Rev. 2012 12 01; 12:1-10.
Apollonio DE, Malone RE. The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation. Am J Public Health. 2010 Jul; 100(7):1188-201.
Dorie E. Apollonio. Interest Groups. Developments in American Politics 6. 2010 Jan 1; 67-83.
Apollonio DE, Bero LA. Evidence and argument in policymaking: development of workplace smoking legislation. BMC Public Health. 2009 Jun 17; 9:189.
Apollonio DE, Malone RE. Turning negative into positive: public health mass media campaigns and negative advertising. Health Educ Res. 2009 Jun; 24(3):483-95.
Todd Lochner, Dorie Apollonio, Rhett Tatum. Wheat from chaff: Third-party monitoring and FEC enforcement actions. Regulation & Governance. 2008 Jun 1; 2(2):216-233.
Apollonio DE, Cain BE, Drutman L. Access and lobbying: Looking beyond the corruption paradigm. Hastings Constitutional Law Quarterly. 2008; 1(36):13-50.
PEGGY LOPIPERO, DORIE E. APOLLONIO, LISA A. BERO. Interest Groups, Lobbying, and Deception: The Tobacco Industry and Airline Smoking. Political Science Quarterly. 2007 Dec 1; 122(4):635-656.
Apollonio DE, Lopipero P, Bero LA. Participation and argument in legislative debate on statewide smoking restrictions. Health Res Policy Syst. 2007 Oct 22; 5:12.
D. E. Apollonio, L. A. Bero. Industry Front Groups: A Tobacco Case Study. Journal of Consumer Protection and Food Safety. 2007 Jul 30; 2(3):341-348.
Apollonio DE, Bero LA. The creation of industry front groups: the tobacco industry and "get government off our back". Am J Public Health. 2007 Mar; 97(3):419-27.
D.E. APOLLONIO, RAYMOND J. RAJA. Term Limits, Campaign Contributions, and the Distribution of Power in State Legislatures. Legislative Studies Quarterly. 2006 May 1; 31(2):259-281.
Apollonio DE, Malone RE. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005 Dec; 14(6):409-15.
D. E. Apollonio. Predictors of Interest Group Lobbying Decisions. The Forum. 2005 Nov 10; 3(3):0000102202154088841097.
Dorie E. Apollonio, Margaret A. Carne. Interest Group Advocacy and the Power of "Magic Words". Election Law Journal Rules Politics and Policy. 2005 Sep 1; 4(3):178-190.
D. E. Apollonio, Raymond J. La Raja. Who Gave Soft Money? The Effect of Interest Group Resources on Political Contributions. The Journal of Politics. 2004 Oct 4; 66(4):1134-1154.
Baldassare MA, Cain BE, Apollonio DE, Cohen JM. The season of our discontent: Voters’ views on California elections. Public Policy Institute of California. 2004.
Brady HE, Putnam RD, Campbell AL, Elms LE, Yonish S, Apollonio DE. Roper Social and Political Trends Data (1973-1994). 2000.
La Raja RJ, Apollonio DE. Term limits affect legislators’ fund raising prowess. Public affairs report. 1999; 5(40).
Brady HE, Apollonio DE, Elms LE. Trends in American political participation, 1973-1994. 1998.
Clayton R, Breathnach A, Martin B, Feiwel M. Hypopigmented sarcoidosis in the negro. Report of eight cases with ultrastructural observations. Br J Dermatol. 1977 Feb; 96(2):119-25.
Weitzman PD, Danson MJ. Citrate synthase. Curr Top Cell Regul. 1976; 10:161-204.
Glenn JK, Goldman J. Task delegation to physician extenders--some comparisons. Am J Public Health. 1976 Jan; 66(1):64-6.
Schmoldt A, Benthe HF, Haberland G. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol. 1975 Sep 01; 24(17):1639-41.